NexImmune, Inc.
NexImmune, Inc. (NEXI) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · NEXI · as of Jun 9, 2026
Key Statistics
Explore NexImmune, Inc. Data
nexi stock data · financialsCompetitors & Peers
nexi competitorsNEXI
BIOCQ
BSPM
ELOX
HTGMQ
MDVLQAbout NexImmune, Inc.
NexImmune, Inc. As a clinical-stage biotechnology firm, NexImmune, Inc. is dedicated to developing potentially curative treatments for individuals battling cancer and severe immune disorders. Their approach leverages…
what is neximmune, inc. · nexi stock overview · neximmune, inc. company profile · who is neximmune, inc. ceo · nexi OTC · neximmune, inc. headquarters · neximmune, inc. business segments
About Stock Overview & Key Data
NexImmune, Inc. (NEXI) is a Healthcare company in the Biotechnology industry, listed on OTC since Feb 12, 2021. As of the latest trading session, NEXI stock price is $0.00, with a market capitalization of $139. The stock has returned — over the past 12 months and — year-to-date.
Frequently Asked Questions
As of the latest trading session, NexImmune, Inc. (NEXI) stock price is $0.00. The stock is traded on OTC under the ticker symbol NEXI. The 52-week range is $0.00 – $1.01.